According to a new market research report launched by Inkwood Research, the Global Alzheimer’s disease diagnostic and therapeutic market was valued at nearly $ 1900 million in 2017 and is anticipated to reach 3600 million by 2026, growing at an estimated CAGR of 7.50% over the forecast period of 2018-2026.